May 14, 2011, Saturday
| TIME | MEETING HALL A | MEETING HALL B | ||||
| 08:30-10:30 | Indolent Lymphomas
 Molecular Pathogenesis of Follicular Lymphoma : Andreas Rosenwald (Würzburg University, Würzburg, Germany) Pathological Insights into Clinical Practice : Ronald Levy ( Stanford University, California, USA) New clinical studies in Follicular NHL : Anas Younes ( MD Anderson Cancer Centeri Texas, USA) Introduction and current therapy for Follicular Lymphoma: Robert Marcus (King's College Hospital, London, United Kingdom) |
|||||
| 10:30 - 11:00 | COFFEE BREAK | |||||
| 11:00 - 12:30 | Chronic Myeloid Leukemia
Current Treatment: Rise of the second generation TKIs: Oliver Ottmann (Universitatsklinik Frankfurt, Medizinische Klinik III, Franfurt) Novel drug development in resistant CML and new strategies directed towards disease cure: Ali Turhan (Division of Laboratory Hematology, University of Poitiers, Hopital Jean Bernard, France) Stem Cell Transplant in Imatinib Era: Any sign for revival? : Ahmet Elmaağaçlı (Department of Bone Marrow Transplantation, University Hospital of Essen, Essen, Germany.) |
New Advances in Pediatric ALL
New genetic abnormalities in ALL and their clinical implications : Rob Pieters (Sophia Children's Hospital, Rotterdam, the Netherlands) Treatment strategies of high-risk childhood ALL : Ching-Hon Pui (St. Jude Children's Research Hospital, Memphis, USA) Treatment strategies of adolescents and young adults with ALL: James Nachman ( University of Chicago Children's Hospital, Chicago,USA) |
||||
| 12:30 - 14:30 | LUNCH | |||||
|
||||||
| 14:30 - 16:00 | Chronic Lymphocytic Leukemia Scientific Chairs: Peter Dreger (University of Heidelberg, Hamburg, Germany) Osman Özcebe (Hacettepe University, Ankara, Turkey) Speakers: Tentative topics are standard treatment and indications : Emili Montserrat ( University of Barcelona, Barcelona, Spain) Novel Perspectives for Resistant Disease: Eva Kimby (Karolinska Institute Huddinge University, Karolinska, Sweden) Stem Cell Transplantation: Peter Dreger (University of Heidelberg, Hamburg, Germany) |
Pediatric Acute Myeloid Leukemia Scientific Chairs: Ursula Creutzig ( University of Münster, Münster, Germany) Mehmet Ertem (Ankara University, Ankara, Turkey) Speakers: The place of stem cell transplantation in 1st remission in pediatric AML : Brenda Gibson (Royal Hospital for Sick Children, Glasgow, United Kingdom) Relapse treatment and new treatment options : Gertjan Kaspers (VU University Medical Center, Amsterdam, Netherland) Risk adapted treatment in pediatric AML : Ursula Creutzig ( University of Münster, Münster, Germany) |
||||
| 16:00 - 16:30 | COFFEE BREAK | |||||
| 16:30 - 18:30 | Aggressive Lymphomas
Pathology and pathophysiology of T-cell lymphomas: Philippe Gaulard (Henri Mondor Hospital, Créteil, France) Conventional Therapy in T-cell Lymphomas: Norbert Schmitz (Asklepios Klinik St.Georg, Hamburg, Germany) New Drugs in the Treatment of T-Cell Lymphomas: Francesco d'Amore (Aarhus University hospital in Aarhurs, Denmark) The role of Stem Cell Transplantation in T cell Lymphomas: Anna Sureda (Hematology Department Addenbrooke's Hospital.Cambridge, UK) |
|||||
